Allergy and hypersensitivity Flashcards
1
Q
Inflammation 1
A
- Physiologic response to injury (physical, chemical, biologic)
- Characterized by cellular and biochemical changes leading to clinical manifestations
- Cellular changes: vasodilation/leakage, leukocyte infiltration, local hypoxia, secondary tissue damage
- Biochemical changes: inflammatory mediator release (histamine, cytokines, eicosanoids)
- Complement, kinin, coag systems activated
2
Q
Inflammaiton 2
A
- Clinical manifestations: redness, hot, swelling, pain, loss of function (LOF)
- Immune system initiates, amplifies, and regulates Ag-specific or molecular pattern-specific inflammatory responses
- Good inflammation: repair, healing, recovery
- Bad inflammation: persistent cellular and biochemical changes, chronic clinical manifestations, LOF, cancer, atherosclerosis
3
Q
Hypersensitivity
A
- Heightened host responsiveness to normally innocuous substances (4 types)
- Type I: mast cell/IgE induced
- Type II/III: IgM/IgG and complement induced
- Type IV: CD4/CD8 mediated
4
Q
Allergy
A
-Immunologically mediated hypersensitivity; IgE mediated vs other mechanisms
5
Q
Atopy
A
-Genetic predisposition to IgE-mediated response
6
Q
Role of the Th2 CD4 cell
A
- Th2 cells induce B cells to switch to IgE Abs (responsible for allergy, asthma)
- Th1 and Th17 responsible for autoimmune diseases (along w/ lack of Tregs)
7
Q
IgE-mediated hypersensitivity
A
- Th2 cell presenting innocuous Ag on MHC binds to B cell, along w/ co-stimulator
- Th2 cell remodels cytoskeleton and begins releasing IL4
- IL4 is released btwn into the cellular synapse and activates the B cell, causing a switch to IgE producing plasma cell
- Both cells also undergo membrane changes
- IgE/Ag complexes bind to Fc(epsilon) receptor on mast cell and causes granule release (histamine, ect)
8
Q
Type I hypersensitivity
A
- Immediate hypersensitivity; Th2, IgE, mast cells, eosinophils involved
- Mast cell-derived mediators released due to IgE-Ag complex binding to Fc receptor of the mast cell
- Also have cytokine-mediated inflammation due to eosinophils/PMNs
9
Q
Type II hypersensitivity
A
- Ab-mediated diseases; IgM, IgG Abs against cell surface or ECM Ags
- Complement and Fc receptor mediated recruitment and activation of PMNs and macrophages (complement not required)
- Opsonization and phagocytosis of cells
- Abnormalities in cellular function function can lead to tissue damage
10
Q
Type III hypersensitivity
A
- Immune complex-mediated disease; Immune complexes of circulating Ags-IgM/G are deposited in vascular basement membrane (inflammation of vessel wall = vasculitis)
- Complement and Fc receptor-mediated recruitment and activation of WBCs
11
Q
Type IV hypersensitivity
A
- CD4 (Th1) T cells produce delayed type hypersensitivity rxn (activating macrophages), not Abs required
- Extended time from Ag exposure to observed response
- CD8 CTLs produce cytolysis
- Macrophage activation and cytokine mediated inflammation (no histamine released)
- Contact dermatitis is type IV, so is type I diabetes
12
Q
IgE and its production
A
- Mast cells and basophils express high affinity receptor Fc(e)
- MHC specificity determines who gets allergic to what
- Environment plays a role; exposure to allergens/microbes drives the change from Th2->Th1 CD4 cells
- This reduces allergic rxns (hygiene hypothesis)
- Microbiome of gut also shapes allergen susceptibility
13
Q
Pathways in generating allergy and asthma 1
A
- Impaired epithelial barrier (infection, allergen exposure) mostly in U and L RT, GI, and skin
- Generation of thymic stromal lymphopoietin (TSLP) by local epithelial cells, fibroblasts, and mast cells
- TSLP activates immature dendritic cells to drive Th2 production, leading to more IL4 and 13 (IgE switch) and IL5 (eosinophil activation)
- Damaged epithelium can also drive inflammation
14
Q
Pathways in generating allergy and asthma 2
A
- Overall there is a net reduction in IL12 (decreases Th1), a net increase in IgE (IL4 and 13) and an increase in eosinophils (IL5)
- IgE mediates inflammatory cascade involving mast cells, basophils, eosinophils, and inflammatory mediators
- IL13 induces SMC proliferation, mucus hypersecretion, goblet cell metaplasia, eosinophil recruitment, fibrosis (asthma)
15
Q
Mast cell vs Basophil
A
- Mast cells are mononuclear and found in tissue
- Basophils are polynuclear and found in blood
- They both have metachromatic granules, release inflammatory mediators, and have Fc(e) receptor